American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$209M |
| 2 |
PepsiCo
PEP
|
+$198M |
| 3 |
McDonald's
MCD
|
+$157M |
| 4 |
Procter & Gamble
PG
|
+$146M |
| 5 |
AbbVie
ABBV
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$285M |
| 2 |
CVS Health
CVS
|
+$284M |
| 3 |
Medtronic
MDT
|
+$266M |
| 4 |
Wells Fargo
WFC
|
+$233M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.72% |
| 4 | Industrials | 11.5% |
| 5 | Consumer Discretionary | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Caleres
CAL
$461M
| $1.34M | ﹤0.01% |
40,733
-102,164
| -71% | -$3.12M |
|
|
LVLT
1102
DELISTED
Level 3 Communications Inc
LVLT
| $1.32M | ﹤0.01% |
+24,558
| New | +$1.28M |
|
1103
Rogers Corp
ROG
$2.46B
| $1.32M | ﹤0.01% |
16,027
-3,913
| -20% | -$308K |
|
|
CMD
1104
DELISTED
Cantel Medical Corporation
CMD
| $1.31M | ﹤0.01% |
27,486
-166
| -0.6% | -$7.35K |
|
|
AIRM
1105
DELISTED
Air Methods Corp
AIRM
| $1.3M | ﹤0.01% |
27,949
+663
| +2% | +$30.4K |
|
1106
International Flavors & Fragrances
IFF
$21.4B
| $1.3M | ﹤0.01% |
11,048
-92,375
| -89% | -$10.4M |
|
1107
SouthState Bank Corp
SSB
$10.8B
| $1.29M | ﹤0.01% |
+18,812
| New | +$1.22M |
|
1108
Progress Software
PRGS
$1.83B
| $1.28M | ﹤0.01% |
47,029
-11,250
| -19% | -$298K |
|
|
TBI
1109
Trueblue
TBI
$309M
| $1.26M | ﹤0.01% |
+51,782
| New | +$1.16M |
|
1110
Bio-Techne
TECH
$11.2B
| $1.26M | ﹤0.01% |
50,216
+8,544
| +21% | +$203K |
|
1111
Delek US
DK
$4.18B
| $1.25M | ﹤0.01% |
31,336
-124,497
| -80% | -$4.12M |
|
|
JOY
1112
DELISTED
Joy Global Inc
JOY
| $1.25M | ﹤0.01% |
31,798
| – | – |
|
1113
Sprott Physical Gold
PHYS
$15.7B
| $1.24M | ﹤0.01% |
127,042
-59,363
| -32% | -$600K |
|
|
MDVN
1114
DELISTED
MEDIVATION, INC.
MDVN
| $1.24M | ﹤0.01% |
19,230
+692
| +4% | +$39.6K |
|
1115
TechnipFMC
FTI
$30.1B
| $1.24M | ﹤0.01% |
+45,035
| New | +$1.32M |
|
|
AM
1116
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $1.23M | ﹤0.01% |
50,934
-813,850
| -94% | -$19.8M |
|
1117
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $1.22M | ﹤0.01% |
5,910
-21,090
| -78% | -$4.35M |
|
1118
Halozyme
HALO
$11.4B
| $1.2M | ﹤0.01% |
84,170
-12,264
| -13% | -$177K |
|
1119
TransDigm Group
TDG
$68.9B
| $1.2M | ﹤0.01% |
5,487
+268
| +5% | +$56.5K |
|
|
PTLA
1120
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.2M | ﹤0.01% |
31,522
-3,308
| -9% | -$114K |
|
|
HTWR
1121
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $1.18M | ﹤0.01% |
13,474
-77
| -0.6% | -$6.54K |
|
|
CSG
1122
DELISTED
CHAMBERS STR PPTYS COM
CSG
| $1.18M | ﹤0.01% |
149,973
+23,026
| +18% | +$189K |
|
1123
Sanofi
SNY
$105B
| $1.17M | ﹤0.01% |
23,603
+700
| +3% | +$33.5K |
|
|
AZPN
1124
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $1.16M | ﹤0.01% |
30,076
-162,737
| -84% | -$6.27M |
|
1125
Euronet Worldwide
EEFT
$2.78B
| $1.15M | ﹤0.01% |
+19,637
| New | +$1.04M |
|
Similar funds
American Century Companies's Q1 2015 Portfolio in Review
As of Q1 2015, American Century Companies held 1,539 positions worth $89.6B, up 1% from $88.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
American Century Companies's Q1 2015 filing shows 151 new, 540 increased, 620 reduced and 191 closed positions. Its largest new stake was Owens Corning: 2,565,659 shares worth $111M. The largest sale was Gilead Sciences, an estimated $285M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q1 2015 buy was Owens Corning: 2,565,659 shares worth $111M.
- American Century Companies added most to EOG Resources in Q1 2015, an estimated $209M increase.
- American Century Companies's biggest Q1 2015 reduction was Gilead Sciences, cutting an estimated $285M.
- American Century Companies fully exited CAREFUSION CORPORATION in Q1 2015, selling an estimated $199M.
- American Century Companies's ten largest holdings make up 12% of its $89.6B portfolio in Q1 2015.
- American Century Companies opened 151 new positions and closed 191 in Q1 2015.
- American Century Companies's portfolio value rose 1% quarter-over-quarter to $89.6B.
Based on American Century Companies's 13F filing for Q1 2015, filed 6 May 2015.